DP303c Versus Trastuzumab Emtansine in in Patients With HER2-positive Advanced Breast Cancer

Primary location

Fudan University Shanghai Cancer Center

Shanghai, Shanghai Municipality, China

Contact

Clinical Trials Information Group officer